TESS V3 Modular Total Shoulder System PMCF

Inclusion Criteria:

• Patient is 18 years or older and skeletally mature

• Patient is capable of understanding the surgeon's explanations and following hisinstructions, able and willing to participate in the follow-up program

• Patient gave consent to take part in the study by signing the Informed Consent Form

• Patient operated from January 2013 and received the Anatomic or Reverse T.E.S.S.® V3Modular Total Shoulder System to relieve pain and restore the joint function

• Patient has adequate quality and quantity of bone stock to support the prosthesis

• Patient meets at least one of the following indications:

For anatomic type:

• Centered osteoarthritis of the shoulder

• Humeral head fractures

• Rheumatoid arthritis (with intact rotator cuff)

• Avascular necrosis of the humeral head

• Revision of a hemi-arthroplasty with a total arthroplasty

• Revision of a reverse prosthesis with an anatomic prosthesis

• Revision to increase the size of the stem (length and/or diameter)

• Revision of a glenoid prosthesis, a glenoid insert or a competitor's prosthesis

For reverse type:

• Offset osteoarthritis of the shoulder

• Massive and non-repairable rotator cuff tears

• Rheumatoid arthritis (with degenerative rotator cuff)

• Revision of an anatomic prosthesis with a reverse prosthesis

• Revision to increase the size of the stem (length and/or diameter)

• Revision of a glenoid prosthesis, a glenoid insert or a competitor's prosthesis

Exclusion Criteria:

• Patient is unwilling or unable to give consent or to comply with the follow-upprogram

• Patient is known to be pregnant or breastfeeding

• Patient has any condition that would, in the judgment of the Investigator, place thepatient at undue risk or interfere with the study

• Patient is a vulnerable subject (prisoner, mentally incompetent or unable tounderstand what participation to the study entails, a known alcohol or drug abuser,anticipated to be non-compliant)

• Patient who displays any of the following contra-indications cannot be included inthis study:

• Local or systemic infections

• Severe muscular, neurological, or vascular deficiency of the affected joint

• Poor bone quality likely to prevent osseointegration or to affect the long-termstability of the implant (Paget's disease, osteoporosis)

• Any concomitant conditions likely to affect the function of the implant

• Allergy to any of the implant components

• Do not use the modular humeral version (screwed connection) in cases where thecorolla cannot be two-thirds covered with bone stock and including the screwedmodular stem/corolla junction